Maternal Hormonal Contraception and Childhood Leukemia Risk

Understanding how maternal hormonal contraception use near pregnancy impacts the risk of childhood leukemia, based on Scandinavian research.

Jan 16, 2025

∙ Paid

A professional medical illustration showcasing a symbolic representation of maternal hormonal contraception and childhood leukemia research. The image features a simplified depiction of a mother and child, with DNA strands subtly incorporated to represent genetic studies. Surrounding the main figures are icons of hormonal pills, intrauterine devices, and scientific data charts to highlight research themes. The background is clean and modern, with soft blue and white tones to convey trust and positivity. The style is approachable and informative, avoiding unsettling details and emphasizing innovation and clarity in public health advancements.

Topline

Recent maternal hormonal contraception use (≤ 3 months before or during pregnancy) is linked to a 70% increased risk of non-lymphoid leukemia in children, with the absolute risk remaining low.

Study Details

This groundbreaking study, led by Marie Hargreave from the Danish Cancer Institute, analyzed 3.2 million children and their mothers across Denm…

Continue reading this post for free, courtesy of Naveen Sankar S.

Or purchase a paid subscription.

Just Healthcare

Maternal Hormonal Contraception and Childhood Leukemia Risk

Understanding how maternal hormonal contraception use near pregnancy impacts the risk of childhood leukemia, based on Scandinavian research.

Topline

Study Details

Continue reading this post for free, courtesy of Naveen Sankar S.